GlobalData

This growth will be partially attributed to the projected increase in assisted reproductive technology (ART) treatment rates in…

As opportunities in developed markets saturate, India Pharma Inc is looking to optimise the growth potential in China. But what…

Deal value in healthcare industry declines in July 2019

The Chinese pharma market is set to be worth $209 billion by 2022 Indian pharmaceutical companies are finding lucrative…

The company’s latest report reveals that patients of age group 18–39 years contributed the highest proportion of the 12-month…

The acute myeloid leukemia (AML) market across the seven major countries (7MM) of the US, France, Germany, Italy, Spain, the UK,…

Asia-Pacific leads the market with a 43 per cent share, followed by North America and Europe

Major drivers of the growth include the projected launch of prophylactic options for the prevention of C. difficile,…

Brazil’s highly attractive pharmaceutical market to approach $30 billion by 2021, says GlobalData

The provision of a single vaccine that can protect the population against all prevalent serogroups is the most important…